GAMA
LOXO

Graticule Asia Macro Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Graticule Asia Macro Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14,000
Closed -$1.12M – 145
2017
Q2 		$1.12M Buy
+14,000
New +$776K 0.05% 100

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Graticule Asia Macro Advisors's LOXO Position: Q3 2017 in Review

Graticule Asia Macro Advisors sold out of Loxo Oncology, Inc (LOXO) in Q3 2017, closing a stake of 14,000 shares — an estimated $1.12M sold.

Graticule Asia Macro Advisors first reported a position in LOXO in Q2 2017 and held it in 1 quarter. The position peaked at $1.12M in Q2 2017. 148 funds tracked by Wall St. Rank hold LOXO as of Q3 2017.

  • Graticule Asia Macro Advisors reported no remaining Loxo Oncology, Inc position as of Q3 2017 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 14,000 Loxo Oncology, Inc shares in Q3 2017, an estimated $1.12M.
  • Graticule Asia Macro Advisors first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's Loxo Oncology, Inc position peaked at $1.12M in Q2 2017.
  • 148 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.